Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ARRon Apr 19, 2013 3:34pm
164 Views
Post# 21276405

RE: Twilight Zone

RE: Twilight Zone

Folks - take a little time to think about this.  If they split RVX 208 from RVX Thereapeutics and we now have 2 separate companies called RVX and Spinco.

If WE sell RVX - NONE of the proceeds from that sale belong to Spinco.  NONE.  The proceeds belong to the shareholders of RVX208.

If the deal involves royalties, (which - as has been discussed here,  would not happen for some years), those royalties would be owed to the former shareholders of RVX208.  NOT Spinco.  There are ways to keep the former owners of RVX registered so that they can get their royalties if and when they occur.

WHY could anyone think those royalites would go to spinco??  in that time period after RVX sells and royalties would be payable a lot of things can happen. Spinco could go public and someone who buys shares in spinco in the interim and had no knowledge of RVX selling off years ealrier would be getting the benefit of royalties from RVX. Spinco could be bought outright by another pharma.  Why would that pharma be getting royalties from the RVX sale years earlier.

So - I repeat - if and when there are any royalties from RVX208 ,they would go to the shareholders of RVX.

 

 

Bullboard Posts